Skip to main content
Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc. — Investor Relations & Filings

Ticker · VERA ISIN · US92337R1014 US Professional, scientific and technical activities
Filings indexed 415 across all filing types
Latest filing 2026-04-09 Annual Report
Country US United States of America
Listing US VERA

About Vera Therapeutics, Inc.

https://veratx.com/

Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological and rare diseases. The company's mission is to change the standard of care and improve patients' lives. Its lead product candidate is atacicept, a novel biologic molecule being developed for the treatment of IgA nephropathy (IgAN), a progressive autoimmune kidney disease. Vera Therapeutics aims to advance its pipeline of innovative therapies to address significant unmet medical needs within immunology.

Recent filings

Filing Released Lang Actions
ARS - Vera Therapeutics, Inc. (0001831828) (Filer)
Annual Report
2026-04-09 English
DEF 14A - Vera Therapeutics, Inc. (0001831828) (Filer)
Proxy Solicitation & Information Statement
2026-04-09 English
4 - Vera Therapeutics, Inc. (0001831828) (Issuer)
Director's Dealing
2026-03-26 English
3 - Vera Therapeutics, Inc. (0001831828) (Issuer)
Director's Dealing
2026-03-26 English
10-K - VERA THERAPEUTICS, INC. (0001831828) (Filer)
Annual Report FY 2025
2026-02-26 English
8-K - VERA THERAPEUTICS, INC. (0001831828) (Filer)
Regulatory Filings
2026-02-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.